Veracyte Inc banner

Intrinsic Value

The intrinsic value of Veracyte Inc (VCYT) under the Base Case is USD per share. Compared with the current market price of 24.295 USD, the stock appears .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

VCYT Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when VCYT is below its intrinsic value
Today Hidden ·
VCYT Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to VCYT

Fundamental Analysis

What Veracyte Does

Biotechnology Health Care

Veracyte is a molecular diagnostics company that makes lab tests doctors use to help diagnose cancer and other serious diseases. Its tests analyze genetic and other biological signals from patient samples, such as tissue or blood, to give more useful answers than traditional methods alone. The company sells these tests to hospitals, doctors, and labs that need better information to guide care.

Headquarters
United States of America US
Employees
755
IPO date
Oct 30, 2013
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

Veracyte insiders are selling more than usual

Insider trading · Last trade on Oct 27, 2026

Sold $15.3m 11 insiders
Bought $0 Nobody bought
Trades by date
Open insider trading

Insiders sell for many reasons, such as taxes or planned sales; purchases are rarer.

Continue VCYT Research

Decided on Veracyte? Get an email when VCYT reaches the price you’d buy at. Free with an account.

Other Veracyte listings

What is the Intrinsic Value of one VCYT stock?

The intrinsic value for Veracyte Inc (VCYT) under the Base Case is USD.

Is VCYT stock undervalued or overvalued?

Compared with the current market price of 24.295 USD, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top